Just look at the announcements TLX have upcoming this year. TLX...

Just look at the announcements TLX have upcoming this year. TLX are purely valued on current FDA approved products, with the entire pipeline of products essentially free. Currently 8x PA with that product alone increasing to take over its entire market, TLX can double on that product alone.

And this pipeline of products, some to be FDA approved this year will see TLX double just in the year, X year on year, and then they start making their income generating streams and it increases again. Atm all income is going into purchasing their competition and their competitors raw ingredient manufacturers to own supply for themselves, so the larger investor community does not yet see what happens when they own everything AND then all the products, manufacturing, and end user radiology therapy drugs all hit the bank at once!

Revenue alone has doubled year on year for the previous two years.

This year TLX have more Phase 3 FDA decisions, each one of these are company making announcements on their own, but with TLX they have multiples, as well as decisions by China on drug approvals. We are at base share price, this company is establishing as a mega-pharma, spending their earnings back into the company, no capital raisings ever needed, this is a producing FDA approved company with none of the traditional risks. Its such a great company and is how mega-pharma starts out as...this is it! This has no doubt the beginnings of CSL and they are using the same playbook, and they 100x from this launchpad...dare anyone dream 5 years from now...

the pipeline: